Bioengineered Microrobot for Targeted and Autonomous Eradication of Helicobacter pylori
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Shali Tan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Xinqiao Hospital, NO.183, Chongqing, China. Hauptthemen laut MEDLINE: Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents, Bioengineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau).
Abstract (Originalsprache)
Helicobacter pylori ( H. pylori ) infection remains a major challenge in gastric disease treatment, with conventional antibiotic therapies hindered by poor gastric retention, lack of specificity, and the growing threat of bacterial resistance. To address these limitations, we introduce a novel bioengineered robotic system inspired by icebreakers, integrating multi‐functional nanomaterials for targeted, autonomous, and efficient H. pylori eradication. Our micro‐robots combine a platinum nanozyme‐based calcium carbonate complex with chitosan (Cs) modification, gastric epithelial cell membranes (CM) coating, and pronase (P) incorporation, enabling selective targeting and autonomous motility. Upon gastric acid exposure, this system undergoes controlled decomposition, generating carbon dioxide to propel movement, releasing pronase to penetrate and degrade mucus barriers, and deploying Pt nanozymes for deep bacterial eradication. This multi‐modal mechanism significantly enhances gastric retention, precision targeting, and therapeutic effectiveness. Our in vitro and in vivo studies validate its superior antibacterial activity, biocompatibility, and its unprecedented ability to mitigate H. pylori ‐induced inflammation while preserving intestinal microbiota balance. By combining bioengineering, nanotechnology, and autonomous propulsion, this innovation represents a paradigm shift in H. pylori therapy, offering a precise, efficient, and resistance‐mitigating alternative to conventional treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Xinqiao Hospital, NO.183, Chongqing, China.
- Department of Mechanical Engineering, University of Manitoba, Winnipeg MB, Manitoba, Canada.
- Department of Biomedical Engineering, Stony Brook University, New York, USA.
- Department of Civil and Environmental Engineering, College of Engineering, Shantou University, Shantou, Guangdong, China.
- Chongqing Institute for Brain and Intelligence, Guangyang Bay Laboratory, Chongqing, China.
ORCID-Profile: Shiming Yang
Förderung
- Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau)
Zitieren
APA
Tan, S., Dan, R., Guo, J., Wei, Q., Xu, K., Luo, Q., Zhang, Y., Fan, C., Zhao, X., Zhu, D., Wang, Q., Xing, M., Yang, S., & Huang, Y. (2026). Bioengineered Microrobot for Targeted and Autonomous Eradication of Helicobacter pylori. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505900
Vancouver
Tan S, Dan R, Guo J, Wei Q, Xu K, Luo Q, et al. Bioengineered Microrobot for Targeted and Autonomous Eradication of Helicobacter pylori. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505900
BibTeX
@article{Tan2026,
author = {Tan, Shali and Dan, Ruijue and Guo, Junfeng and Wei, Qinglin and Xu, Kaige and Luo, Qiang and Zhang, Yuchen and Fan, Chaoqiang and Zhao, Xiaoyan and Zhu, Donghui and Wang, Quan and Xing, Malcolm and Yang, Shiming and Huang, Yu},
title = {Bioengineered Microrobot for Targeted and Autonomous Eradication of Helicobacter pylori},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505900}
}
EUVIMED